Hemoglobin A, featured prominently on the Thalassemia and Hemoglobinopathy Comprehensive (COMP) panel, is a critical component in diagnosing and managing blood disorders. This panel is an essential tool used to detect various forms of thalassemia and hemoglobinopathies, conditions characterized by abnormal hemoglobin production. Hemoglobin A, the most common form of hemoglobin in adults, is composed of two alpha and two beta globin chains. The Thalassemia and Hemoglobinopathy COMP panel measures the percentage of Hemoglobin A in the blood, which is crucial for diagnosing conditions like beta-thalassemia or sickle cell disease. In normal individuals, Hemoglobin A constitutes the majority of hemoglobin. However, in disorders like beta-thalassemia, there is a reduced production of beta globin chains, leading to a lower percentage of Hemoglobin A. Similarly, in sickle cell disease, a mutation in the beta globin gene results in abnormal hemoglobin, known as Hemoglobin S, reducing the proportion of Hemoglobin A. The accurate quantification of Hemoglobin A through this panel is instrumental in differentiating between various hemoglobinopathies and thalassemia syndromes, thereby guiding appropriate treatment strategies.
Hemoglobin A
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.